QR Code

Recommendations from the COST action CA17116 (SPRINT) for the standardization of perinatal derivative preparation and in vitro testing

Many preclinical studies have shown that birth-associated tissues, cells and their secreted factors, otherwise known as perinatal derivatives (PnD), possess various biological properties that make them suitable therapeutic candidates for the treatment of numerous pathological conditions. Nevertheles...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Aleksandar Janev, Asmita Banerjee, Adelheid Weidinger, Jure Dimec, Brane Leskošek, Antonietta Rosa Silini, Tina Cirman, Susanne Wolbank, Taja Železnik Ramuta, Urška Dragin Jerman, Assunta Pandolfi, Roberta Di Pietro, Michela Pozzobon, Bernd Giebel, Günther Eissner, Polonca Ferk, Ingrid Lang-Olip, Francesco Alviano, Olga Soritau, Ornella Parolini, Mateja Erdani Kreft
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Frontiers Media S.A. 2023-11-01
Rangatū:Frontiers in Bioengineering and Biotechnology
Ngā marau:
standardization
perinatal derivatives
recommendations
CA17116 (SPRINT)
PnD e-questionnaire
Urunga tuihono:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1258753/full
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite